Showing results (161-170 of 318) with videos related to
Sort By:
Pageof 32
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeuticsJanis M Taube, Jérôme Galon, Lynette M Sholl, et al.Cancer Research|July 19, 2014
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLCJeremy H Tchaicha, Esra A Akbay, Abigail Altabef, et al.The American Journal of Surgical Pathology|October 7, 2017
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital TractJelena Mirkovic, Marie McFarland, Elizabeth Garcia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung CancerAntonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.JCO Precision Oncology|January 7, 2022
Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLCMichael L Cheng, Marina S D Milan, Rubii M Tamen, et al.JAMA Dermatology|September 5, 2014
Novel genetic mutations in a sporadic port-wine stainChristine Guo Lian, Lynette M Sholl, Labib R Zakka, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2016
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the LungDavid H Hwang, Lynette M Sholl, Vanesa Rojas-Rudilla, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypesAndres M Acosta, Lynette M Sholl, Brendan C Dickson, et al.Cold Spring Harbor Molecular Case Studies|June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosisPanieh Terraf, Lynette M Sholl, Matthew S Davids, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung CancerBiagio Ricciuti, Gonzalo Recondo, Liam F Spurr, et al.Pageof 32